Plagiarism Policy

PLAGIARISM POLICY

INNOVATION JOURNAL OF PHARMACEUTICAL SCIENCE

1. Introduction

INJOPHARS (Innovation Journal of Pharmaceutical Science) is committed to maintaining academic integrity and originality in scholarly publications. Plagiarism in any form is considered a serious violation of publication ethics. All authors are required to ensure that their submitted manuscripts represent original scholarly work and appropriately acknowledge the ideas, words, data, and contributions of other researchers.

2. Definition of Plagiarism

Plagiarism refers to the use of another person's work, ideas, statements, data, or research findings without proper acknowledgment or citation. It includes, but is not limited to:

  • Direct plagiarism: Copying text or material from another source without quotation marks or appropriate citation.
  • Self-plagiarism: Reusing substantial parts of one's previously published work without proper acknowledgment or disclosure.
  • Mosaic plagiarism: Combining phrases, sentences, or ideas from different sources without adequate attribution.
  • Paraphrasing plagiarism: Rewriting another author's ideas without providing proper citation.
  • Data plagiarism: Using tables, figures, images, datasets, or research results from other sources without appropriate acknowledgment or permission when required.

3. Similarity Screening

All manuscripts submitted to INJOPHARS may undergo similarity screening as part of the initial editorial evaluation. The editorial team uses similarity-checking tools to identify overlapping text and potentially unattributed material.

PROPOSED MAXIMUM SIMILARITY INDEX

20%

Manuscripts are expected to have a similarity index of no more than 20%, subject to editorial assessment.

The similarity index is not the sole basis for determining plagiarism. The editorial team evaluates the similarity report contextually, considering the source of overlap, properly cited quotations, references, common terminology, and the originality of the manuscript. A manuscript with a low similarity score may still contain plagiarism, while a higher score does not automatically establish misconduct.

4. Responsibilities of Authors

Authors submitting manuscripts to INJOPHARS must:

  • Submit original work that has not been plagiarized from other sources.
  • Provide accurate and complete citations for all sources used.
  • Use quotation marks and appropriate references when reproducing exact statements from other works.
  • Obtain permission for copyrighted materials when required.
  • Disclose any substantial overlap with their previously published work.
  • Ensure that all data, images, figures, and tables are properly attributed.
  • Revise manuscripts when requested by the editorial team to address similarity concerns.

5. Editorial Actions

If plagiarism or inappropriate textual similarity is identified, INJOPHARS may take appropriate action depending on the nature, extent, and severity of the violation.

Minor Similarity or Citation Issues

Authors may be asked to revise the manuscript, improve paraphrasing, provide missing citations, or clarify the source of overlapping text.

Substantial Plagiarism

Manuscripts containing substantial unattributed material may be rejected during editorial screening or at any stage of the publication process.

Plagiarism Identified After Publication

If plagiarism is confirmed after publication, the journal may issue a correction, publish a retraction, or take other appropriate measures to protect the integrity of the scholarly record.

6. Duplicate and Redundant Publication

Authors must not submit manuscripts that have been published previously or are under consideration by another journal. Reuse of previously published material must be appropriately acknowledged and disclosed. Substantial duplication of previously published content without proper disclosure may result in rejection or other editorial action.

7. Use of Third-Party Materials

Authors are responsible for ensuring that third-party materials, including figures, photographs, illustrations, tables, and other copyrighted content, are used with appropriate acknowledgment and permission where necessary. All reproduced or adapted materials must clearly identify their original sources.

8. AI-Generated Content and Plagiarism

The use of generative artificial intelligence does not exempt authors from their responsibility to ensure originality, accuracy, and proper attribution. AI-generated content must not be presented as original human research or used to fabricate references, data, or research findings. Authors must follow the journal's Generative AI Policy and disclose relevant use of AI tools.

9. Appeals and Clarifications

Authors who disagree with an editorial decision related to plagiarism or similarity screening may submit a written explanation and relevant supporting evidence to the editorial team. All appeals will be considered objectively and handled in accordance with the journal's publication ethics principles.

Commitment to Originality

INJOPHARS is committed to publishing original, responsible, and ethically sound scholarly contributions. Every author, reviewer, and editor shares responsibility for protecting academic integrity and maintaining public trust in scientific publications.

INJOPHARS – INNOVATION JOURNAL OF PHARMACEUTICAL SCIENCE

Published by PT. IRMEX DIGITAL AKADEMIKA